Last reviewed · How we verify

NCT05865184

Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD

Status unknown Last updated 18 May 2023
What this trial tests

trial testing Data collection in COPD in 100 participants. Status unknown.

Timeline
28 September 2022
Primary endpoint
6 June 2024
6 June 2024

Quick facts

Lead sponsorSensorum Health Inc.
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date28 September 2022
Primary completion6 June 2024
Estimated completion6 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sensorum Health Inc.

Who can join

65 and older, any sex, with COPD or Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sensorum Health (Sensorum) is conducting a pilot study to determine if Sensorum's proprietary passive sensor network can be used to identify signals of early health decompensation in subjects prior to a hospitalization for chronic disease exacerbation or other ambulatory care sensitive conditions. Successful early detection would provide a window of opportunity to intervene outside of the acute setting in future interventional studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Data collection

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Sensorum Health Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05865184.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing